Physician profile
Bryan Dale Den Hartog
NPI 1043299738
$8,993,015.97
in general payments reported to CMS, 2019-2025
23 companies · $109K in 2025
The $109K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340K · 2020: $338K · 2021: $308K · 2022: $7.3M · 2023: $350K · 2024: $250K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $637K · Consulting Fee: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Acquisitions: $12K · Travel and Lodging: $3,191 · Food and Beverage: $2,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $637,029.48 |
| Consulting Fee | $31,187.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,756.25 |
| Acquisitions | $12,411.50 |
| Travel and Lodging | $3,191.39 |
| Food and Beverage | $2,559.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $6,945,819.48 | 2022-2023 | Motoband |
| Depuy Synthes Products, INC. | $617,757.01 | 2019-2024 | Hammerlock |
| Smith+Nephew, INC. | $616,776.28 | 2019-2025 | Salto Talaris Total Ankle Prosthesis, Integra Xt, Cadence |
| Stryker Corporation | $425,392.58 | 2020-2025 | Maxlock Extreme, Ortholoc 3di, Anchorage |
| Integra Lifesciences Corporation | $212,756.62 | 2019-2021 | |
| Wright Medical Technology, INC. | $160,909.59 | 2019-2020 | |
| Djo, LLC | $8,144.18 | 2021-2022 | |
| Ascension Orthopedics, INC. | $1,650.00 | 2019 | |
| Crossroads Extremity Systems, LLC | $1,077.32 | 2019-2021 | |
| Gemini Medical LLC | $950.42 | 2021 | |
| Arthrex, INC. | $670.02 | 2021 | |
| Biotissue Holdings INC. | $235.44 | 2024 | |
| Paragon 28, INC. | $187.69 | 2019-2024 | Apex 3d |
| Exactech, INC. | $125.00 | 2019 | |
| Unify Medical | $109.00 | 2023 | Amplio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $100.02 | 2025 | |
| Orthofix Medical, INC. | $93.72 | 2019-2025 | Physio-Stim |
| Biogennix, LLC | $81.64 | 2021 | |
| Zavation Medical Products, LLC | $55.74 | 2025 | |
| Zimmer Biomet Holdings, INC. | $49.51 | 2021 | |
| Tela Bio, INC. | $49.30 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Rmr Ortho INC | $25.41 | 2025 | A'Tomic |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,393,122.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Den Hartog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.